Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2001
Reliability:
1 (reliable without restriction)

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2001
Report date:
2001

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Version / remarks:
and EU Method B.1 92/69/EEC
GLP compliance:
yes (incl. QA statement)
Test type:
acute toxic class method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
methyl 5-amino-4-cyano-3-(2-methoxy-2-oxoethyl)thiophene-2-carboxylate
Cas Number:
674773-12-7
Molecular formula:
C10H10N2O4S
IUPAC Name:
methyl 5-amino-4-cyano-3-(2-methoxy-2-oxoethyl)thiophene-2-carboxylate
Test material form:
solid: crystalline
Details on test material:
- Name of test material (as cited in study report):
- Molecular formula (if other than submission substance):
- Molecular weight (if other than submission substance):
- Smiles notation (if other than submission substance):
- InChl (if other than submission substance):
- Structural formula attached as image file (if other than submission substance): see Fig.
- Substance type:
- Physical state: solid
- Analytical purity:
- Impurities (identity and concentrations):
- Composition of test material, percentage of components:
- Isomers composition:
- Purity test date:
- Lot/batch No.: 812691/019
- Expiration date of the lot/batch:
- Radiochemical purity (if radiolabelling):
- Specific activity (if radiolabelling):
- Locations of the label (if radiolabelling):
- Expiration date of radiochemical substance (if radiolabelling):
- Stability under test conditions:
- Storage condition of test material:
- Other: brown to yellow greenish powder

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Breeder: Iffa Crédo, 69210, L'Arbrelse, France
- Age at study initiation: 6 weeks old
- Weight at study initiation: males: 174 ± 4 g
females: 147 ± 2 g
- Fasting period before study: overnight (ca. 18 hours)
- Housing: one to seven of the same sex / cage during acclimation period and 5 rats of the same sex and group / cage
during the treatment period in polycarbonate cages with stainless steel lid (48 x 27 x 20 cm)
- Diet (e.g. ad libitum): ad libitum, A04 C pelleted diet by UAR, 91360 Villemoisson-sur-Orge, France
- Water (e.g. ad libitum): ad libitum, drinking water, filtered by FG Millipore membrane 0.22 micron
- Acclimation period: 5 days


ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 ± 2 C
- Humidity (%): 30-70 %
- Air changes (per hr): 12 / hour (filtered, non-recycled air)
- Photoperiod (hrs dark / hrs light): 12/12 h

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
other: MC (methylcellulose) 0.5 %
Details on oral exposure:
VEHICLE
- Concentration in vehicle: 200 mg / ml vehicle suspension
- Amount of vehicle (if gavage): 10 ml/kg

MAXIMUM DOSE VOLUME APPLIED: 10 ml / kg

Doses:
2000 mg / kg bodyweight
No. of animals per sex per dose:
5 males / 5 females
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations : frequently during the hours administration following then once a day
weighing: days 1, 8 and 15
- Necropsy of survivors performed: yes (macroscopic examination).
- Other examinations performed: none.

Results and discussion

Effect levelsopen allclose all
Sex:
female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Sex:
male
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Mortality:
No mortality
Clinical signs:
other: No clinical signs
Gross pathology:
No apparent abnormalities were observed at necropsy in any animal.
Other findings:
None.

Applicant's summary and conclusion

Interpretation of results:
not classified
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
Under our experimental conditions the oral LD50 of the test susbtance is higher than 2000 mg/kg in rats.
No signs of toxicity were observed at this dose. The test substance should not be classified according to EU regulations.